Literature DB >> 15864099

The role of type-specific antibodies in colonization and infection by Helicobacter pylori.

Ali A Akhiani1.   

Abstract

PURPOSE OF REVIEW: Helicobacter pylori is a Gram-negative spiral bacterium that colonizes the stomach of humans, causing gastritis, peptic ulcer disease, or gastric cancer. H. pylori infection accounts for a high percentage of mortality and morbidity rates in developing as well as developed countries. H. pylori bacteria reside in the mucus layer covering the gastric epithelium, and therefore the type of protective measures that could confer resistance appear to be limited. Although H. pylori infection stimulates strong local and systemic specific IgA and IgG antibody production, the influence of antibodies on bacterial colonization and gastric inflammation is still controversial. RECENT
FINDINGS: Recent studies in experimental animal models have indicated a non-essential role of specific antibodies for host resistance against H. pylori infection. Recent data show that protection is mediated by T cells, CD4 T helper type 1 cells, in particular. Antibodies are not only dispensable for protection, but they impair both the elimination of bacteria and the development of gastritis. This effect appears to be IgA-dependent and is not a function of specific IgM or IgG antibodies.
SUMMARY: This review highlights the recent advances in our understanding of how antibodies may influence the development of gastric inflammation and bacterial colonization. Such information can significantly increase our basic knowledge of immune regulation and protection against H. pylori infection, but can also indicate new strategies for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864099     DOI: 10.1097/01.qco.0000168382.86024.14

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  7 in total

1.  Immunoglobulin G and immunoglobulin M anti-Helicobacter pylori antibodies-diagnostic and prognostic value in gastritis.

Authors:  Nikhil Moorchung; Pushkar Mendiratta; Vibha Dutta
Journal:  Med J Armed Forces India       Date:  2012-04-21

Review 2.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Helicobacter pylori seropositivity in fibromyalgia syndrome.

Authors:  Nuray Akkaya; Semih Akkaya; Yusuf Polat; Meral Turk; Tufan Turk; Elif Turhal; Fusun Sahin
Journal:  Clin Rheumatol       Date:  2010-12-01       Impact factor: 2.980

4.  H. pylori vaccines: why we still don't have any.

Authors:  Songhua Zhang; Leonard Moise; Steven F Moss
Journal:  Hum Vaccin       Date:  2011-11-01

5.  Parenteral immunization with a cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) adjuvanted Helicobacter pylori vaccine induces protective immunity against H. pylori infection in mice.

Authors:  Jing Chen; Youxiu Zhong; Yu Liu; Chongfa Tang; Yanbin Zhang; Bo Wei; Wangxue Chen; Meiying Liu
Journal:  Hum Vaccin Immunother       Date:  2020-04-16       Impact factor: 3.452

6.  Helicobacter pylori-infection status and childhood living conditions are associated with signs of allergic diseases in an occupational population.

Authors:  Petra Ina Pfefferle; Alexander Krämer
Journal:  Eur J Epidemiol       Date:  2008-08-14       Impact factor: 8.082

7.  Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations.

Authors:  Jennifer M Taylor; Melanie E Ziman; Julie Fong; Jay V Solnick; Michael Vajdy
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.